Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The Department of Health and Human Services announced it is shuttering a nationwide program that offered free COVID-19 tests to community organizations, citing it bled taxpayer funds despite the ...

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on thimerosal ...

Citing concerns about mRNA technology, the Trump administration has pulled funding for a vaccine, even though Moderna says it causes "a rapid, potent and durable immune response." ...